Hyperparathyroidism
Hyperparathyroidism
Definition
Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.
Also known as hyperparathyroidism — per MONDO
Also identified as
- DOID 13543 per MONDO
- ICD9 252.0 per MONDO
- ICD9 252.00 per MONDO
- MESH D006961 per MONDO
- NCIT C48259 per MONDO
- SCTID 66999008 per MONDO
- UMLS C0020502 per MONDO
Affected Organs
| Organ | Involvement | Source |
|---|---|---|
| Craniocervical region | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Craniocervical region | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Endocrine gland | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Neck | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Neck | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
| Parathyroid glands | Disease Has Associated Anatomic Site | NCIT · CC BY 4.0 |
| Parathyroid glands | Disease Has Primary Anatomic Site | NCIT · CC BY 4.0 |
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Paricalcitol | may prevent | MEDRT · Public domain (U.S. Government work) |
| Calcitriol | may treat | MEDRT · Public domain (U.S. Government work) |
| Doxercalciferol | may treat | MEDRT · Public domain (U.S. Government work) |
| Paricalcitol | may treat | MEDRT · Public domain (U.S. Government work) |